Addressing Serialisation Challenges to Achieve Business Benefits and Best Practice Deployment in the Pharmaceutical Sector

|

article image
This white paper sets out a roadmap for the successful implementation of a serialization programme applicable to pharmaceutical companies of any size and complexity. It is based on practical experience of implementing serialization for some of the world’s largest companies.

Spotlight

Jarun Pharmaceuticals Pvt. Ltd.

We Take The Opportunity To Introduce Ourselves As Up-Comming Pharmaceutical Marketing Company From Ahmedabad. We Are One Of The Group Companies Of J.J. Parikh & Bros and J. Bipinchandra & co. Who Enjoys 60 Years Of Reputation As Leading Distribution House Of Gujarat, With Annual Turn-Over Of More Than 40 Crores.

OTHER ARTICLES

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | April 10, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | April 10, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

Spotlight

Jarun Pharmaceuticals Pvt. Ltd.

We Take The Opportunity To Introduce Ourselves As Up-Comming Pharmaceutical Marketing Company From Ahmedabad. We Are One Of The Group Companies Of J.J. Parikh & Bros and J. Bipinchandra & co. Who Enjoys 60 Years Of Reputation As Leading Distribution House Of Gujarat, With Annual Turn-Over Of More Than 40 Crores.

Events